Skip to main content

Advertisement

SpringerLink
Log in

Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately

  • Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia in humans. One of its important features is the tendency to become more persistent over time, even in the absence of underlying progressive heart disease. Conversion and maintenance of sinus rhythm by pharmacological or electrical methods become increasingly difficult the longer the arrhythmia persists. Electrical, mechanical, structural, and autonomic remodeling processes have been implicated in the mechanisms of AF initiation, perpetuation, and progression. Prevention or reversal of these remodeling processes can halt the progression of the disease. Cardioversion is a powerful tool and rhythm control is a widely used strategy in the management of AF. However, important questions remain unanswered regarding not only if, but also when to perform cardioversion. There are observations from past trials and clinical situations that support attempting to restore sinus rhythm, but further prospective randomized clinical trials are needed. Optimal timing of cardioversion remains somewhat uncertain, but it appears to be some time after the first few hours and before the first few months: the earlier, the better, but not always, and maybe not immediately, and it has to be tailored to the clinical situation and its many variables. This review is intended to summarize the evidence supporting early intervention for the prevention of remodeling in patients with AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004;110:1042–6.

    Article  PubMed  Google Scholar 

  2. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation. 1998;98:946–52.

    Article  CAS  PubMed  Google Scholar 

  3. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes 3rd NA, et al. ACCF/AHA/HRS. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:223–42.

    Article  PubMed  Google Scholar 

  4. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation. 2007;115:3050–6.

    Article  PubMed  Google Scholar 

  5. Nattel S, Guasch E, Savelieva I, Cosio FG, Valverde I, Halperin JL, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J. 2014;35:1448–56.

    Article  PubMed  Google Scholar 

  6. Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J. 2004;68:568–72.

    Article  PubMed  Google Scholar 

  7. Cosio FG, Aliot E, Botto GL, Heidbuchel H, Geller CJ, Kirchhof P, et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace. 2008;10:21–7.

    Article  PubMed  Google Scholar 

  8. • Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–68. This is one of the landmark research papers in which it was shown that remodeling was induced and was implicated in the persistence of atrial fibrillation.

  9. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802–9.

    Article  CAS  PubMed  Google Scholar 

  10. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943–59.

    Article  PubMed  Google Scholar 

  11. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1:184–92.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, Olgin JE. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation. 2000;101:1185–91.

    Article  CAS  PubMed  Google Scholar 

  13. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588–95.

    Article  CAS  PubMed  Google Scholar 

  14. Anter E, Callans DJ, Wyse DG. Pharmacological and electrical conversion of atrial fibrillation to sinus rhythm is worth the effort. Circulation. 2009;120:1436–43.

    Article  PubMed  Google Scholar 

  15. Nattel S. Electrophysiologic remodeling: are ion channels static players or dynamic movers? J Cardiovasc Electrophysiol. 1999;10:1553–6.

    Article  CAS  PubMed  Google Scholar 

  16. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation. 1996;94:2968–74.

    Article  CAS  PubMed  Google Scholar 

  17. • Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol. 2001;33:2083–94. This is the second landmark research paper about cellular remodeling in atrial fibrillation.

  18. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87–95.

    Article  CAS  PubMed  Google Scholar 

  19. • Avitall B, Bi J, Mykytsey A, Chicos A. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. Heart Rhythm. 2008;5:839–45. This study investigated long-term remodeling and showed significant persistent fibrosis despite months of recovery in sinus rhythm, even in the absence of heart failure.

  20. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996;94:1600–6.

    Article  CAS  PubMed  Google Scholar 

  21. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 1997;30:1785–92.

    Article  CAS  PubMed  Google Scholar 

  22. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124:2264–74.

    Article  CAS  PubMed  Google Scholar 

  23. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415:219–26.

    Article  CAS  PubMed  Google Scholar 

  24. Wakili R, Voigt N, Kaab S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011;121:2955–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001;103:769–77.

    Article  CAS  PubMed  Google Scholar 

  26. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91:265–325.

    Article  PubMed  Google Scholar 

  27. Daoud EG, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation. 1997;96:1542–50.

    Article  CAS  PubMed  Google Scholar 

  28. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, et al. Ionic determinants of functional reentry in a 2-d model of human atrial cells during simulated chronic atrial fibrillation. Biophys J. 2005;88:3806–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rostagno C, Olivo G, Comeglio M, Bertini G, Gensini GF, Galanti G. Left atrial size changes in patients with paroxysmal lone atrial fibrillation. An echocardiographic follow-up. Angiology. 1996;47:797–801.

    Article  CAS  PubMed  Google Scholar 

  30. Suarez GS, Lampert S, Ravid S, Lown B. Changes in left atrial size in patients with lone atrial fibrillation. Clin Cardiol. 1991;14:652–6.

    Article  CAS  PubMed  Google Scholar 

  31. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157–63.

    Article  CAS  PubMed  Google Scholar 

  32. Kazui T, Henn MC, Watanabe Y, Kovacs SJ, Lawrance CP, Greenberg JW, et al. The impact of 6 weeks of atrial fibrillation on left atrial and ventricular structure and function. J Thorac Cardiovasc Surg. 2015;150:1602–1608 e1601.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Anne W, Willems R, Holemans P, Beckers F, Roskams T, Lenaerts I, et al. Self-terminating af depends on electrical remodeling while persistent af depends on additional structural changes in a rapid atrially paced sheep model. J Mol Cell Cardiol. 2007;43:148–58.

    Article  CAS  PubMed  Google Scholar 

  34. Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007;76:442–52.

    Article  CAS  PubMed  Google Scholar 

  35. Corradi D. Atrial fibrillation from the pathologist’s perspective. Cardiovasc Pathol. 2014;23:71–84.

    Article  PubMed  Google Scholar 

  36. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724–30.

    Article  CAS  PubMed  Google Scholar 

  37. Akoum N, Wilber D, Hindricks G, Jais P, Cates J, Marchlinski F, et al. MRI assessment of ablation-induced scarring in atrial fibrillation: analysis from the DECAAF Study. J Cardiovasc Electrophysiol. 2015;26:473–80.

    Article  PubMed  Google Scholar 

  38. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF Study. JAMA. 2014;311:498–506.

    Article  CAS  PubMed  Google Scholar 

  39. Raitt MH, Kusumoto W, Giraud G, McAnulty JH. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:507–12.

    Article  PubMed  Google Scholar 

  40. Hobbs WJ, Fynn S, Todd DM, Wolfson P, Galloway M, Garratt CJ. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation. 2000;101:1145–51.

    Article  CAS  PubMed  Google Scholar 

  41. Ausma J, van der Velden HM, Lenders MH, van Ankeren EP, Jongsma HJ, Ramaekers FC, et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation. 2003;107:2051–8.

    Article  PubMed  Google Scholar 

  42. Lehto M, Jurkko R, Parikka H, Mantynen V, Vaananen H, Montonen J, et al. Reversal of atrial remodeling after cardioversion of persistent atrial fibrillation measured with magnetocardiography. Pacing Clin Electrophysiol. 2009;32:217–23.

    Article  PubMed  Google Scholar 

  43. Arora R. Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol. 2012;5:850–9.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Yu L, Scherlag BJ, Sha Y, Li S, Sharma T, Nakagawa H, et al. Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle. Heart Rhythm. 2012;9:804–9.

    Article  PubMed  Google Scholar 

  45. Tan AY, Zhou S, Ogawa M, Song J, Chu M, Li H, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation. 2008;118:916–25.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Doshi RN, Wu TJ, Yashima M, Kim YH, Ong JJ, Cao JM, et al. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation. 1999;100:876–83.

    Article  CAS  PubMed  Google Scholar 

  47. Yu L, Scherlag BJ, Li S, Fan Y, Dyer J, Male S, et al. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013;10:428–35.

    Article  PubMed  Google Scholar 

  48. Zhang L, Po SS, Wang H, Scherlag BJ, Li H, Sun J, et al. Autonomic remodeling: how atrial fibrillation begets atrial fibrillation in the first 24 hours. J Cardiovasc Pharmacol. 2015;66:307–15.

    Article  CAS  PubMed  Google Scholar 

  49. Hohnloser SH, Kuck KH. Randomized trial of rhythm or rate control in atrial fibrillation: The Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J. 2001;22:801–2.

    Article  CAS  PubMed  Google Scholar 

  50. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) Study. J Am Coll Cardiol. 2003;41:1690–6.

    Article  PubMed  Google Scholar 

  51. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study G. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–40.

    Article  PubMed  Google Scholar 

  52. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. Atrial fibrillation follow-up investigation of rhythm management I. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.

    Article  CAS  PubMed  Google Scholar 

  53. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Congestive heart failure I. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667–77.

    Article  CAS  PubMed  Google Scholar 

  54. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, et al. Investigators of the Polish How to Treat Chronic Atrial Fibrillation S. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: The results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest. 2004;126:476–86.

    Article  PubMed  Google Scholar 

  55. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1–76.

    Article  PubMed  Google Scholar 

  56. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation. 2001;104:292–6.

    Article  CAS  PubMed  Google Scholar 

  57. • Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109:1509–13. AFFIRM trial initially showed no benefit in rhythm versus rate control but post hoc analyses showed a trend towards benefit in rhythm control.

  58. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-rhythm study. Circ J. 2009;73:242–8.

    Article  PubMed  Google Scholar 

  59. Osmanagic A, Moller S, Osmanagic A, Sheta HM, Vinther KH, Egstrup K. Effect of early direct current cardioversion on the recurrence of atrial fibrillation in patients with persistent atrial fibrillation. Am J Cardiol. 2015;116:225–9.

    Article  PubMed  Google Scholar 

  60. Damluji AA, Al-Damluji MS, Marzouka GR, Coffey JO, Viles-Gonzalez JF, Cohen MG, Moscucci M, Myerburg RJ, Mitrani RD. New-onset versus prior history of atrial fibrillation: Outcomes from the affirm trial. Am Heart J. 2015;170:156–163, 163 e151

  61. Walters TE, Nisbet A, Morris GM, Tan G, Mearns M, Teo E, Lewis N, Ng A, Gould P, Lee G, Joseph S, Morton JB, Zentner D, Sanders P, Kistler PM, Kalman JM. Progression of atrial remodeling in patients with high-burden atrial fibrillation: Implications for early ablative intervention. Heart Rhythm. 2015.

  62. Oral H, Ozaydin M, Sticherling C, Tada H, Scharf C, Chugh A, et al. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion. J Cardiovasc Electrophysiol. 2003;14:182–5.

    Article  PubMed  Google Scholar 

  63. Schwartzman D, Musley S, Koehler J, Warman E. Impact of atrial fibrillation duration on postcardioversion recurrence. Heart Rhythm. 2005;2:1324–9.

    Article  PubMed  Google Scholar 

  64. Gronberg T, Hartikainen JE, Nuotio I, Biancari F, Vasankari T, Nikkinen M, et al. Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FINCV Study. Pacing Clin Electrophysiol. 2015;38:368–75.

    Article  PubMed  Google Scholar 

  65. Kuppahally SS, Foster E, Shoor S, Steimle AE. Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med. 2009;2:39.

    Article  PubMed  PubMed Central  Google Scholar 

  66. • Toso E, Blandino A, Sardi D, Battaglia A, Garberoglio L, Miceli S, et al. Electrical cardioversion of persistent atrial fibrillation: acute and long-term results stratified according to arrhythmia duration. Pacing Clin Electrophysiol. 2012;35:1126–34. This research paper shows that long-term results are strongly related with AF duration at time of cardioversion and a cutoff of >6 months helps in selecting patients that can take greater advantage of the procedure.

Download references

Author information

Authors and Affiliations

  1. Clinical Cardiac Electrophysiology, Bluhm Cardiovascular Institute, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA

    Paloma G. Piña & Alexandru B. Chicos

Authors
  1. Paloma G. Piña
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexandru B. Chicos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandru B. Chicos.

Ethics declarations

Conflict of Interest

Paloma G. Piña and Alexandru B. Chicos declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Cardiovascular Disease and Stroke

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piña, P.G., Chicos, A.B. Early Cardioversion in Atrial Fibrillation: Earlier Is Better, but Not Always and (Maybe) Not Immediately. Curr Atheroscler Rep 19, 3 (2017). https://doi.org/10.1007/s11883-017-0638-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-017-0638-1

Keywords

Search

Navigation